Participant characteristics

Glioma gradeaMeningiomabControls
IIIIIIV
Sex (n)
 Male7854324
 Female64221011
Median age4250595759
 Range24–7029–7327–7943–7436–84
IDH status(n)
 WT1372NANA
 Mutated1294NANA
MGMT (n)
 Non-methylated0435NANA
 Methylated6438NANA
 NA743NANA
Steroidnoyesyesyesno

aFor grade II, n = 13 patients and 13 tissue samples. For Grade III, n = 12 patients and 12 tissue samples. For Grade IV, n = 76 samples and 113 tissue samples

bGrade I and II

n = number